Azalea Therapeutics, Inc.
PrivateLast Round
Series A
Nov 4, 2025
Total Funding Raised
$65M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Azalea Therapeutics, Inc. is a biotechnology company that develops Enveloped Delivery Vehicle (EDV) technology to enable precision in vivo genome engineering for cancer immunotherapies and other immune-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azalea Therapeutics, Inc. Comparables
Compare Azalea Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbbVie | 73% | |
| CREATE Medicines | 70% | |
| Bristol Myers Squibb | 70% | |
Azalea Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 4, 2025 |
Key People
Founding team and executive leadership
Azalea Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Yosemite | Series A |
| Sozo Ventures | Series A |
| Third Rock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
Monthly visitors increased 80% MoM, reaching 8.1K.
- Nov 4, 2025
$82M round completed.
Azalea Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Azalea Therapeutics, Inc.'s valuation, stock price, and market status.